Research & Education

Researchers believe arsenic-induced lung tumors caused by different molecular mechanisms than common lung cancer

Latest in November issue of Journal of Thoracic Oncology


IASLC Names Fred R. Hirsch, MD, PhD as New CEO

Dr. Hirsch will replace Dr. Paul A. Bunn, Jr. after World Conference in 2013

The International Association for the Study of Lung Cancer (IASLC) Board of Directors has selected Fred R.

Accelerated radiotherapy more efficient than current practice

Latest study recommends accelerated radiotherapy for un-resected NSCLC patients

DENVER – Radiotherapy with or without chemotherapy is increasingly being used in the curative treatment for un-resected non-small cell lung cancer

Researchers study survival in African American versus Caucasian lung cancer patients

Study finds that no racial difference of people of same socioeconomic status

DENVER – According to the American Cancer Society, an estimated 160,340 lung cancer deaths occurred in the United States in 2012, accounting for 28

Chemotherapy helps elderly patients with small cell lung cancer

Treatment associated with 6-month improvement, even in patients older than 80

DENVER – Although numerous randomized clinical trials have demonstrated a benefit of chemotherapy for patients with small-cell lung cancer (SCLC),

Canadian group gives guideline recommendations for lung cancer screening

Evidence-based recommendations available in October issue of JTO

DENVER – Lung cancer is the most common cause of cancer death in Ontario.